ERBB2 and breast cancer: In a recent study, Bertucci et al. (15) performed whole-exome sequencing of 617 tumor samples from patients with metastatic BC and revealed that the mutation frequency of NF1 is negatively correlated with the prognosis of patients with HR +/HER-2- mBC.